Actively Recruiting
bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
Led by University of Arizona · Updated on 2025-10-15
100
Participants Needed
2
Research Sites
113 weeks
Total Duration
On this page
Sponsors
U
University of Arizona
Lead Sponsor
U
University of Illinois at Urbana-Champaign
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of the bpMedManage study is to rigorously test the efficacy of a smartphone technology to help improve high blood pressure medication adherence among older adults with mild cognitive impairment (MCI) in a 16-week randomized controlled trial. A total of 100 older adults will be recruited. There will be two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on an education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes on primary and secondary measures will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.
CONDITIONS
Official Title
bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 60 or older
- Community-dwelling older adults
- Fluent in English as self-reported
- Adequate self-reported vision and hearing ability
- Self-reported challenges with memory, thinking, or concentration
- Able to self-manage at least one prescribed blood pressure medication
- Owns and uses a smartphone
- No history of major depression or other mental health diagnoses by self-report
- No diagnosis of dementia or neurological disorders such as stroke, traumatic brain injury, or Parkinson's disease
- Scores between 27-37 on the TICS-M and between 20-26 on the Montreal Cognitive Assessment (MoCA)
- Willing to participate for at least 4 months
You will not qualify if you...
- Diagnosis of dementia
- Living in an assisted living or skilled nursing facility
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University of Arizona
Tucson, Arizona, United States, 85721
Actively Recruiting
2
University of Illinois, Urbana-Champaign
Champaign, Illinois, United States, 61820
Actively Recruiting
Research Team
K
Kathleen Insel, PhD
CONTACT
R
Raksha Mudar, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here